IPO Arc Weekly, Nov 9, 2026
IPO Arc Weekly of 9 November 2026 · data through the close of Nov 9, 2026
The US IPO market in the week from Mon, Nov 2, 2026 to Sun, Nov 8, 2026, with data through the close of Mon, Nov 9, 2026: no IPOs priced this week; 9 lock-up dates in the next 14 days, 44 phase changes and 8 new research signals.
New IPOs
US operating-company IPOs priced from Mon, Nov 2, 2026 to Sun, Nov 8, 2026 (SPACs are not covered), with the first and the last close.
No IPOs priced this week.
Lock-ups in the next 14 days
Lock-up expiries and early-release dates from Tue, Nov 10, 2026 to Mon, Nov 23, 2026. Lock-up lengths come from each company's final prospectus; dates marked estimated use the pricing date plus 180 days.
BXDCBlackstone Digital Infrastructure Trust Inc.
Lock-up expiry on Tue, Nov 10, 2026, from the final prospectus.
- Date
- Nov 10, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- -16.5%
- Phase
- Lock-up window
CBRSCerebras Systems Inc.
Lock-up expiry on Tue, Nov 10, 2026, from the final prospectus. Part of the locked shares was released early from Thu, Jun 25, 2026.
- Date
- Nov 10, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- -47.7%
- Phase
- Lock-up window
EROKEagleRock Land, LLC
Lock-up expiry on Tue, Nov 10, 2026, from the final prospectus.
- Date
- Nov 10, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- +14.8%
- Phase
- Lock-up window
MWCMicware Co., Ltd.
Lock-up expiry on Tue, Nov 10, 2026, from the final prospectus.
- Date
- Nov 10, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- -85.4%
- Phase
- Lock-up window
EXYNExyn Technologies, Inc.
Lock-up expiry on Wed, Nov 11, 2026, from the final prospectus.
- Date
- Nov 11, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- -70.3%
- Phase
- Lock-up window
VIDAVida Global Inc.
Lock-up expiry on Wed, Nov 11, 2026, from the final prospectus.
- Date
- Nov 11, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- -82.3%
- Phase
- Lock-up window
LCLNLincoln International, Inc.
Lock-up expiry on Mon, Nov 16, 2026, from the final prospectus.
- Date
- Nov 16, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- +34.8%
- Phase
- Lock-up window
OPTHOptimi Health Corp.
Lock-up expiry on Mon, Nov 16, 2026, from the final prospectus.
- Date
- Nov 16, 2026
- Type
- Lock-up expiry
- Source
- Prospectus
- Vs offer
- -60.0%
- Phase
- Lock-up window
BSPBending Spoons S.p.A.
Earliest early lock-up release in the prospectus terms on about Mon, Nov 23, 2026, if its conditions are met; it has not triggered yet. Standard expiry: Mon, Dec 28, 2026.
- Date
- Nov 23, 2026
- Type
- Earliest early release
- Source
- Prospectus
- Vs offer
- +43.2%
- Phase
- Distribution
Phase changes
IPOs whose lifecycle phase at the last close of the week differs from the week before. Returns to a phase held in the previous 10 sessions are not counted. Lock-up milestones first, then larger deals.
INIOINNIO N.V.
Moved from Distribution to Lock-up window this week, at the close of Tue, Nov 3, 2026. Lock-up window: From 20 trading days before to 10 after the estimated lock-up expiry. Close $13.77 on Fri, Nov 6, 2026, -49.0% vs the offer price.
- From
- Distribution
- To
- Lock-up window
- Changed
- Nov 3, 2026
- Vs offer
- -49.0%
QNTQuantinuum Inc.
Moved from Distribution to Lock-up window this week, at the close of Tue, Nov 3, 2026. Lock-up window: From 20 trading days before to 10 after the estimated lock-up expiry. Close $37.57 on Fri, Nov 6, 2026, -37.4% vs the offer price.
- From
- Distribution
- To
- Lock-up window
- Changed
- Nov 3, 2026
- Vs offer
- -37.4%
AADXApplied Aerospace & Defense, Inc.
Moved from Distribution to Lock-up window this week, at the close of Mon, Nov 2, 2026. Lock-up window: From 20 trading days before to 10 after the estimated lock-up expiry. Close $9.67 on Fri, Nov 6, 2026, -51.6% vs the offer price.
- From
- Distribution
- To
- Lock-up window
- Changed
- Nov 2, 2026
- Vs offer
- -51.6%
LFTOLiftoff Mobile, Inc.
Moved from Distribution to Lock-up window this week, at the close of Tue, Nov 3, 2026. Lock-up window: From 20 trading days before to 10 after the estimated lock-up expiry. Close $18.13 on Fri, Nov 6, 2026, -21.2% vs the offer price.
- From
- Distribution
- To
- Lock-up window
- Changed
- Nov 3, 2026
- Vs offer
- -21.2%
SSMRSunshine Silver Mining & Refining Co
Moved from Distribution to Lock-up window this week, at the close of Tue, Nov 3, 2026. Lock-up window: From 20 trading days before to 10 after the estimated lock-up expiry. Close $13.27 on Fri, Nov 6, 2026, -1.7% vs the offer price.
- From
- Distribution
- To
- Lock-up window
- Changed
- Nov 3, 2026
- Vs offer
- -1.7%
XEX-Energy, Inc.
Moved from Lock-up window to Valley this week, at the close of Thu, Nov 5, 2026. Valley: After the lock-up window, below its 50-day average and 30%+ off the high. Close $10.43 on Fri, Nov 6, 2026, -54.7% vs the offer price.
- From
- Lock-up window
- To
- Valley
- Changed
- Nov 5, 2026
- Vs offer
- -54.7%
NHPNational Healthcare Properties, Inc.
Moved from Lock-up window to Valley this week, at the close of Thu, Nov 5, 2026. Valley: After the lock-up window, below its 50-day average and 30%+ off the high. Close $15.24 on Fri, Nov 6, 2026, +27.0% vs the offer price.
- From
- Lock-up window
- To
- Valley
- Changed
- Nov 5, 2026
- Vs offer
- +27.0%
YSWYYesway, Inc.
Moved from Lock-up window to Accumulation this week, at the close of Tue, Nov 3, 2026. Accumulation: After the lock-up window, back above its 50-day average but below 90% of the high. Close $24.69 on Fri, Nov 6, 2026, +23.5% vs the offer price.
- From
- Lock-up window
- To
- Accumulation
- Changed
- Nov 3, 2026
- Vs offer
- +23.5%
ELMTElmet Group Co.
Moved from Lock-up window to Valley this week, at the close of Thu, Nov 5, 2026. Valley: After the lock-up window, below its 50-day average and 30%+ off the high. Close $19.62 on Fri, Nov 6, 2026, +40.1% vs the offer price.
- From
- Lock-up window
- To
- Valley
- Changed
- Nov 5, 2026
- Vs offer
- +40.1%
DETXLIBERTY DEFENSE HOLDINGS, LTD.
Moved from Lock-up window to Valley this week, at the close of Tue, Nov 3, 2026. Valley: After the lock-up window, below its 50-day average and 30%+ off the high. Close $1.22 on Fri, Nov 6, 2026, -72.9% vs the offer price.
- From
- Lock-up window
- To
- Valley
- Changed
- Nov 3, 2026
- Vs offer
- -72.9%
CTYCITY THERAPEUTICS, INC.
Moved from Hype to Distribution this week, at the close of Wed, Nov 4, 2026. Distribution: More than 15% below its running high, before the lock-up window. Close $18.25 on Fri, Nov 6, 2026, +1.4% vs the offer price.
- From
- Hype
- To
- Distribution
- Changed
- Nov 4, 2026
- Vs offer
- +1.4%
ASPEAspen Neuroscience, Inc.
Moved from Hype to Distribution this week, at the close of Fri, Nov 6, 2026. Distribution: More than 15% below its running high, before the lock-up window. Close $12.44 on Fri, Nov 6, 2026, -17.1% vs the offer price.
- From
- Hype
- To
- Distribution
- Changed
- Nov 6, 2026
- Vs offer
- -17.1%
TRXBTRex Bio, Inc.
Moved from Hype to Distribution this week, at the close of Thu, Nov 5, 2026. Distribution: More than 15% below its running high, before the lock-up window. Close $13.26 on Fri, Nov 6, 2026, -5.3% vs the offer price.
- From
- Hype
- To
- Distribution
- Changed
- Nov 5, 2026
- Vs offer
- -5.3%
CGONCG Oncology, Inc.
Moved from Valley to Recovery this week, at the close of Fri, Nov 6, 2026. Recovery: After the lock-up window, within 10% of its running high. Close $75.99 on Fri, Nov 6, 2026, +299.9% vs the offer price.
- From
- Valley
- To
- Recovery
- Changed
- Nov 6, 2026
- Vs offer
- +299.9%
JANJanus Living, Inc.
Moved from Distribution to Hype this week, at the close of Thu, Nov 5, 2026. Hype: First 20 trading days, or trading near its high with RSI above 60. Close $31.99 on Fri, Nov 6, 2026, +59.9% vs the offer price.
- From
- Distribution
- To
- Hype
- Changed
- Nov 5, 2026
- Vs offer
- +59.9%
New research signals
Signals of the published research rules, first recorded after the closes of this week. Past figures are hypothetical close-to-close results on 2014–2025 IPOs, computed on Oct 30, 2026, before trading costs and borrow fees. The rules were selected on these same years, so the figures likely overstate what live signals will do; delisted companies are missing, which probably understates declines. The figures start at the close of the signal session; this email arrives up to a week later. Past results do not predict future results. The rules run independently, so one IPO can carry buy and sell signals at the same time; each label reports only its own rule's history.
AGMBAgomab Therapeutics NV
Rule C1: buy signal for 40 sessions (Capitulation), signal of Mon, Nov 2, 2026. Trigger: At least 60% below the highest close since listing, with RSI(14) below 30, after trading day 40 (first time only). Past signals (652, deals of $50M and over): rose 53% · median +2.1% · dropped 25%+ during the hold 33%. Buy signals passed on returns relative to IPOs of the same year, size and age, most of which fall after listing. A buy signal can beat its peers and still lose money.
- Signal
- Rule C1: buy signal for 40 sessions
- Rule
- C1, Capitulation
- Signal date
- Nov 2, 2026
OFRMOnce Upon a Farm, PBC
Rule C1: buy signal for 40 sessions (Capitulation), signal of Mon, Nov 2, 2026. Trigger: At least 60% below the highest close since listing, with RSI(14) below 30, after trading day 40 (first time only). Past signals (652, deals of $50M and over): rose 53% · median +2.1% · dropped 25%+ during the hold 33%. Buy signals passed on returns relative to IPOs of the same year, size and age, most of which fall after listing. A buy signal can beat its peers and still lose money.
- Signal
- Rule C1: buy signal for 40 sessions
- Rule
- C1, Capitulation
- Signal date
- Nov 2, 2026
LIMENeutron Holdings, Inc.
Rule E1: sell or short signal for 60 sessions (Weak earnings reaction), signal of Wed, Nov 4, 2026. Trigger: After the first or second earnings release (SEC 8-K item 2.02), the stock trails the S&P 500 by 10% or more over the two sessions around the release. Deals of $50M or more. Past signals (186, deals of $50M and over): fell 70% · median -13.6% · rallied 25%+ during the hold 33%. Short-selling risk: losses on a short position have no limit and can exceed the amount put up; brokers can demand more margin, recall borrowed shares or close the position; borrow fees and any dividends are owed while short and are not in the figures shown; recent IPOs are often hard to borrow and prone to squeezes.
- Signal
- Rule E1: sell or short signal for 60 sessions
- Rule
- E1, Weak earnings reaction
- Signal date
- Nov 4, 2026
AMBQAmbiq Micro, Inc.
Rule C1: buy signal for 40 sessions (Capitulation), signal of Thu, Nov 5, 2026. Trigger: At least 60% below the highest close since listing, with RSI(14) below 30, after trading day 40 (first time only). Past signals (652, deals of $50M and over): rose 53% · median +2.1% · dropped 25%+ during the hold 33%. Buy signals passed on returns relative to IPOs of the same year, size and age, most of which fall after listing. A buy signal can beat its peers and still lose money.
- Signal
- Rule C1: buy signal for 40 sessions
- Rule
- C1, Capitulation
- Signal date
- Nov 5, 2026
RTSNRetension Pharmaceuticals, Inc.
Rule F1: sell signal for 100 sessions (Microcap deal), signal of Thu, Nov 5, 2026. Trigger: The IPO raised less than $50M. Checked at trading day 20. Past signals (387, deals under $50M): fell 73% · median -29.0% · rallied 25%+ during the hold 50%. Deal under $50M: published as a sell signal only, because shorting such shares is usually impractical (hard to borrow, high borrow fees, frequent squeezes).
- Signal
- Rule F1: sell signal for 100 sessions
- Rule
- F1, Microcap deal
- Signal date
- Nov 5, 2026
RTSNRetension Pharmaceuticals, Inc.
Rule R20: sell signal for 100 sessions (Day-20 risk tier), signal of Thu, Nov 5, 2026. Trigger: Risk score from eight price features at trading day 20, in the top third (bearish) or bottom third (bullish) of 2014–2025 scores. Past signals (280, deals under $50M): fell 76% · median -33.9% · rallied 25%+ during the hold 50%. Deal under $50M: published as a sell signal only, because shorting such shares is usually impractical (hard to borrow, high borrow fees, frequent squeezes).
- Signal
- Rule R20: sell signal for 100 sessions
- Rule
- R20, Day-20 risk tier
- Signal date
- Nov 5, 2026
TRXBTRex Bio, Inc.
Rule R20: buy signal for 100 sessions (Day-20 risk tier), signal of Thu, Nov 5, 2026. Trigger: Risk score from eight price features at trading day 20, in the top third (bearish) or bottom third (bullish) of 2014–2025 scores. Past signals (389, deals of $50M and over): rose 46% · median -2.7% · dropped 25%+ during the hold 39%. Buy signals passed on returns relative to IPOs of the same year, size and age, most of which fall after listing. A buy signal can beat its peers and still lose money.
- Signal
- Rule R20: buy signal for 100 sessions
- Rule
- R20, Day-20 risk tier
- Signal date
- Nov 5, 2026
ELWTElauwit Connection, Inc.
Rule C1: buy signal for 40 sessions (Capitulation), signal of Fri, Nov 6, 2026. Trigger: At least 60% below the highest close since listing, with RSI(14) below 30, after trading day 40 (first time only). Past signals (357, deals under $50M): rose 42% · median -6.8% · dropped 25%+ during the hold 49%. Buy signals passed on returns relative to IPOs of the same year, size and age, most of which fall after listing. A buy signal can beat its peers and still lose money.
- Signal
- Rule C1: buy signal for 40 sessions
- Rule
- C1, Capitulation
- Signal date
- Nov 6, 2026
Live track record
Every live signal of the published rules is recorded after the close of its signal session and is not edited afterwards; the track record page shows every signal, open signals with their result to date.
Coming up
Pricings scheduled in the Nasdaq IPO calendar, then the companies that filed to go public from Mon, Nov 2, 2026 to Sun, Nov 8, 2026. Expected dates, price ranges and deal sizes often change, and deals can be postponed or withdrawn.
RZRARezera Inc.
Expected to price on Thu, Nov 12, 2026; price range $11.00-13.00; about $249M; NASDAQ Global.
- Expected
- Nov 12, 2026
- Price range
- $11.00-13.00
- Deal size
- $249M
- Exchange
- NASDAQ Global
Filed to go public on Thu, Nov 5, 2026; proposed deal size $31M.
- Filed
- Nov 5, 2026
- Deal size
- $31M
BENEBEHNEH Ltd
Filed to go public on Fri, Nov 6, 2026; proposed deal size $29M.
- Filed
- Nov 6, 2026
- Deal size
- $29M
Filed to go public on Fri, Nov 6, 2026; proposed deal size $29M.
- Filed
- Nov 6, 2026
- Deal size
- $29M
Research
No new research this week.
Not investment advice. IPO Arc publishes impersonal, rule-based research identical for every reader. It does not know your situation and does not recommend any security to you. Results simulated on past data are hypothetical, have limits and do not predict future results. Lock-up terms are extracted from each company's final prospectus and may contain errors. Prices and company profiles come from Yahoo Finance and may be delayed or inaccurate. Insider transactions are shown as filed on SEC Form 4 and may be late, amended or incomplete. Not affiliated with Nasdaq, NYSE or the SEC. IPO calendar data comes from Nasdaq. Readers are responsible for their own investment decisions. IPO Arc is not paid by the companies it covers. The people who run IPO Arc do not hold or trade the securities named in its signals.
Research signals only, not investment advice. Lock-up terms come from prospectuses; prices from Yahoo Finance and may be delayed or wrong; insider transactions as filed on SEC Form 4.
Get IPO Arc Weekly by email
One email a week, usually on Monday: new US IPOs of the past week, lock-up expiries ahead, lifecycle phase changes, new research signals and the track record. Free; only an email address is needed. Past issues